| 000 | 01865cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030808.0 | ||
| 008 | 130317s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.03.M.Sc.2012.Mo.C | ||
| 100 | 0 | _aMohamed Ibrahem Mohamed Elsayed | |
| 245 | 1 | 0 |
_aClinical significance of serum level of interleukin -6 (IL-6) as a tumor marker for hepatocellular carcinoma (HCC) / _cMohamed Ibrahem Mohamed Elsayed ; Supervised Yasser Hussein Nassar , Fatma Mohamed Taha , Mohamed Ali Ezz Elarab |
| 246 | 1 | 5 | _aالقيمة الاكلينيكية لقياس مستوى الانترلوكين-6 فى الدم كأحد دلالات الأورام لمرض سرطان الكبد |
| 260 |
_aCairo : _bMohamed Ibrahem Mohamed Elsayed , _c2012 |
||
| 300 |
_a111P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Medical Biochemistry | ||
| 520 | _aHepatocellular carcinoma (HCC) is the fifth most common cancer in the world . Currently standrad surveillance includes a combination of 6 monthly ultrasound scans (USS) and serum Ü- fetoprotein measurements but this strategy does not reliably detect the disease in its early stages . An increasing body of evidence indicates a key role of the cytokine IL -6 in the process of liver damage and carcinogenesis | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAlpha-1-fucosidase | |
| 653 | 4 | _aGlypican-3 | |
| 653 | 4 | _aHepatitis C virus | |
| 700 | 0 |
_aFatma Mohamed Taha , _eSupervisor |
|
| 700 | 0 |
_aMohamed Ali Ezz Elarab , _eSupervisor |
|
| 700 | 0 |
_aYasser Hussein Nassar , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c42085 _d42085 |
||